ResMed shares are experiencing significant volatility, with some reports indicating the stock is trading up, while others show it has hit a 52-week low or is falling. The company recently reported earnings, which beat expectations, but this has not uniformly translated to a positive impact on the stock price. The stock's value has fallen substantially, with some analysts still seeing potential for recovery and a higher fair value.